Carter Todd Alfred
SEC CIK 1944011 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | CSO | 145.7K | — | $367.9K | 23 | 2022-12-31 | 2026-02-24 |
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-24 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $3.76 | -4,174 | 145.7K | -3% | -$15.7K | |
| 2026-02-20 | 2026-02-18 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $3.44 | -3,301 | 149.9K | -2% | -$11.4K | |
| 2026-02-11 | 2026-02-10 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $3.85 | -3,525 | 153.2K | -2% | -$13.6K | |
| D | 2026-02-10 | 2026-02-06 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | A - Grant | $0.00 | +33.0K | 156.7K | +27% | $0 |
| D | 2025-02-24 | 2025-02-20 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $4.26 | -3,305 | 77.7K | -4% | -$14.1K |
| D | 2025-02-24 | 2025-02-21 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | A - Grant | $0.00 | +46.0K | 123.7K | +59% | $0 |
| 2025-02-12 | 2025-02-11 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $4.45 | -5,413 | 81.0K | -6% | -$24.1K | |
| 2025-01-15 | 2025-01-14 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $5.13 | -1,191 | 86.4K | -1% | -$6,110 | |
| M | 2024-02-22 | 2024-02-20+ | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $7.50 | -3,967 | 91.0K | -4% | -$29.8K |
| D | 2024-02-16 | 2024-02-09 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | A - Grant | $0.00 | +38.5K | 91.6K | +73% | $0 |
| 2024-01-19 | 2024-01-17 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $7.18 | -1,266 | 53.1K | -2% | -$9,090 | |
| D | 2023-09-18 | 2023-09-15 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale+OE | $8.16 | -10.5K | 54.4K | -16% | -$85.7K |
| D | 2023-09-18 | 2023-09-15 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | M - OptEx | $2.85 | +5,000 | 64.9K | +8% | +$14.2K |
| 2023-07-10 | 2023-07-06 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $10.80 | -5,500 | 59.9K | -8% | -$59.4K | |
| D | 2023-07-05 | 2023-06-30 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | M - OptEx | $2.85 | +5,000 | 70.4K | +8% | +$14.2K |
| D | 2023-07-05 | 2023-06-30 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale+OE | $11.41 | -5,000 | 65.4K | -7% | -$57.0K |
| 2023-03-22 | 2023-03-20 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $7.76 | -2,193 | 65.4K | -3% | -$17.0K | |
| D | 2023-02-22 | 2023-02-17 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | A - Grant | $0.00 | +34.0K | 68.3K | +99% | $0 |
| D | 2023-02-22 | 2023-02-17 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $7.45 | -738 | 67.6K | -1% | -$5,498 |
| 2023-02-15 | 2023-02-13 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $7.67 | -797 | 34.3K | -2% | -$6,113 | |
| M | 2023-01-19 | 2023-01-17 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $9.85 | -1,106 | 35.1K | -3% | -$10.9K |
| 2023-01-10 | 2022-12-31 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | A - Grant | $5.17 | +388 | 36.6K | +1% | +$2,006 | |
| 2023-01-10 | 2023-01-06 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | CSO | S - Sale | $6.41 | -388 | 36.2K | -1% | -$2,487 |
Purchase Sale Sale after option exercise All abbreviations